What is the optimal dose of ASA for risk reduction in atherosclerotic CV disease? U.S. study compares 81 mg vs 325 mg ASA to lower cardiovascular risk and mortality in patients with established atherosclerotic cardiovascular disease. Vancouver sends drug decriminalization pitch to Health Canada for federal review NACI to update guidance to recommend vaccine mixing in some situations: CBC Saskatchewan pharmacies meeting demand for Covid-19 vaccines Sponsored How technology can support your pharmacy’s future AstraZeneca recipients can get Moderna or Pfizer for second dose: NACI Several companies recalling lots of irbesartan, losartan and valsartan drugs Pharmacy students lend a hand with COVID-19 vaccinations Class act Webinars Upcoming live webinars from Canadian Healthcare Network, as well as links to on-demand versions of past webinars. Ontarians 80 and older start booking second COVID-19 vaccine appointments First Previous 693 694 695 696 697 Next Last
